Patients who developed the composite endpoint of ischemic stroke, TIA, or AFX (17.7% of the total number of patients, out of which 62.31% had IPH on admission) also had higher plasma BLVRB levels upon admission compared to those who did not (852.9 ± 778.7 vs. 573.8 ± 540.6 MFI, HR = 1.348, CI [1.010–1.799]; p = 0.042); however, this association did not remain statistically significant once adjusted for age and sex (p = 0.075) (Figure 2D,E). Here, BLVRB is linked to acquired factor X deficiency.